Human HMGB1 does not induce eryptosis in vitro

Maryna Tkachenko 1 2, Anatolii Onishchenko 2, Dmytro Butov 3, Tetyana Butova 2, Anton Tkachenko 2 *
More Detail
1 Department of Internal Medicine No. 2, Clinical Immunology and Allergology named after academician L.T. Malaya, Kharkiv National Medical University, Kharkiv, Ukraine
2 Research Institute of Experimental and Clinical Medicine, Kharkiv National Medical University, Kharkiv, Ukraine
3 Department of Phthisiology and Pulmonology, Kharkiv National Medical University, Kharkiv, Ukraine
* Corresponding Author
J CLIN MED KAZ, Volume 19, Issue 2, pp. 33-37. https://doi.org/10.23950/jcmk/11934
OPEN ACCESS
Download Full Text (PDF)

ABSTRACT

Aim: To study the ability of human high mobility group box protein 1 (HMGB1) to induce eryptosis in vitro.
Material and methods: Blood collected from six healthy volunteers was incubated with HMGB1 (0-0.2-1-5 ng per ml). Eryptosis of red blood cells was assessed by Annexin V staining and 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) staining by flow cytometry. The forward scatter (FSC) fluorescence was used to evaluate the morphology of red blood cells.
Results: Exposure of erythrocytes to HMGB1 did not affect the morphology of erythrocytes, evidenced by no changes in the percentage of cells with small volume, i.e. shrunken cells, and erythrocytes with large volume, i.e. enlarged cells. HMGB1 had no impact on phosphatidylserine externalization, which is confirmed by the absence of statistically significant changes in the amount of phosphatidylserine-displaying cells and the mean fluorescence intensity (MFI) values of Annexin V-FITC in cells exposed to different concentrations of HMGB1. Furthermore, H2DCFDA staining revealed that the HMGB1 did not induce oxidative stress.
Conclusion: HMGB1 does not promote eryptosis of human erythrocytes at concentrations of up to 5 ng/ml.
Key words: high mobility group box protein 1, erythrocytes, inflammation, cell death

CITATION

Tkachenko M, Onishchenko A, Butov D, Butova T, Tkachenko A. Human HMGB1 does not induce eryptosis in vitro. J CLIN MED KAZ. 2022;19(2):33-7. https://doi.org/10.23950/jcmk/11934

REFERENCES

  • Yuan S, Liu Z, Xu Z, Liu J, Zhang J. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. J Hematol Oncol. 2020;13(1):91. https://doi.org/10.1186/s13045-020-00920-3
  • Andersson U, Ottestad W, Tracey KJ. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med. 2020;26(1):42. https://doi.org/10.1186/s10020-020-00172-4
  • Andersson U, Yang H, Harris H. Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin Ther Targets. 2018;22(3):263-277. https://doi.org/10.1080/14728222.2018.1439924
  • Magna M, Pisetsky DS. The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med. 2014;20(1):138-146. https://doi.org/10.2119/molmed.2013.00164
  • Harker JA, Snelgrove RJ. A Not-So-Good Way to Die? Respiratory Syncytial Virus-induced Necroptotic Cell Death Promotes Inflammation and Type 2-mediated Pathology. Am J Respir Crit Care Med. 2020;201(11):1321-1323. https://doi.org/10.1164/rccm.202003-0533ED
  • Kim SW, Lee JK. Role of HMGB1 in the Interplay between NETosis and Thrombosis in Ischemic Stroke: A Review. Cells. 2020;9(8):1794. https://doi.org/10.3390/cells9081794
  • Volchuk A, Ye A, Chi L, Steinberg BE, Goldenberg NM. Indirect regulation of HMGB1 release by gasdermin D. Nat Commun. 2020;11(1):4561. https://doi.org/10.1038/s41467-020-18443-3
  • Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol. 2006;291(6):C1318-25. https://doi.org/10.1152/ajpcell.00616.2005
  • Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191-5. https://doi.org/10.1038/nature00858
  • Yang H, Wang H, Andersson U. Targeting Inflammation Driven by HMGB1. Front Immunol. 2020;11:484. https://doi.org/10.3389/fimmu.2020.00484
  • Zhong H, Li X, Zhou S, Jiang P, Liu X, Ouyang M, et al. Interplay between RAGE and TLR4 Regulates HMGB1-Induced Inflammation by Promoting Cell Surface Expression of RAGE and TLR4. J Immunol. 2020;205(3):767-775. https://doi.org/10.4049/jimmunol.1900860
  • Ferrara M, Chialli G, Ferreira LM, Ruggieri E, Careccia G, Preti A, et al. Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions. Front Immunol. 2020;11:1122. https://doi.org/10.3389/fimmu.2020.01122
  • Janko C, Filipović M, Munoz LE, Schorn C, Schett G, Ivanović-Burmazović I, et al. Redox modulation of HMGB1-related signaling. Antioxid Redox Signal. 2014;20(7):1075-85. https://doi.org/10.1089/ars.2013.5179
  • Tang D, Kang R, Zeh HJ 3rd, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal. 2011;14(7):1315-1335. https://doi.org/10.1089/ars.2010.3356
  • Tang D, Kang R. “HMGB1 in Cell Death,” in Cell Death - Autophagy, Apoptosis and Necrosis, ed. T. M. Ntuli (London: IntechOpen), 2015.
  • Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene. 2010;29(38):5299-310. https://doi.org/10.1038/onc.2010.261
  • Yang M, Yang X, Wang S, Xu L, Ke S, Ding X, et al. HMGB1-induced endothelial cell pyroptosis is involved in systemic inflammatory response syndrome following radiofrequency ablation of hepatic hemangiomas. Am J Transl Res. 2019;11(12):7555-7567.
  • Xu Z, Jin Y, Yan H, Gao Z, Xu B, Yang B, et al. High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity. Toxicol Lett. 2018;296:39-47. https://doi.org/10.1016/j.toxlet.2018.08.003
  • Zhu X, Messer JS, Wang Y, Lin F, Cham CM, Chang J, et al. Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. J Clin Invest. 2015;125(3):1098-110. https://doi.org/10.1172/JCI76344
  • Onishchenko A, Myasoedov V, Yefimova S, Nakonechna O, Prokopyuk V, Butov D, et al. UV Light-Activated GdYVO4:Eu3+ Nanoparticles Induce Reactive Oxygen Species Generation in Leukocytes Without Affecting Erythrocytes In Vitro. Biol Trace Elem Res. 2021. https://doi.org/10.1007/s12011-021-02867-z
  • Tkachenko A, Kot Y, Prokopyuk V, Onishchenko A, Bondareva A, Kapustnik V, et al. Food additive E407a stimulates eryptosis in a dose-dependent manner. Wien Med Wochenschr. 2021. https://doi.org/10.1007/s10354-021-00874-2
  • Bratosin D, Tcacenco L, Sidoroff M, Cotoraci C, Slomianny C, Estaquier J, et al. Active caspases-8 and -3 in circulating human erythrocytes purified on immobilized annexin-V: a cytometric demonstration. Cytometry A. 2009;75(3):236-44. https://doi.org/10.1002/cyto.a.20693
  • Pretorius E, du Plooy JN, Bester J. A Comprehensive Review on Eryptosis. Cell Physiol Biochem. 2016;39(5):1977-2000. https://doi.org/10.1159/000447895
  • Lang F, Lang E, Föller M. Physiology and pathophysiology of eryptosis. Transfus Med Hemother. 2012;39(5):308-14. https://doi.org/10.1159/000342534
  • Egler J, Lang F. Triggering of Eryptosis, the Suicidal Erythrocyte Death, by Perifosine. Cell Physiol Biochem. 2017;41(6):2534-2544. https://doi.org/10.1159/000475977
  • Chen F, Liu Z, Li W, Li D, Yan B. The significance of serum HMGB1 level in humans with acute paraquat poisoning. Sci Rep. 2019;9:7448. https://doi.org/10.1038/s41598-019-43877-1
  • Tsujimoto H, Kounami S, Ichikawa T, Hama T, Suzuki H. Serum high mobility group box protein 1 (HMGB1) levels reflect clinical features of childhood hemophagocytic lymphohistiocytosis. J Blood Med. 2019; 10:301-306.
  • Paudel YN, Shaikh MF, Chakraborti A, Kumari Y, Aledo-Serrano Á, Aleksovska K, et al. HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction. Front Neurosci. 2018;12:628. https://doi.org/10.3389/fnins.2018.00628
  • Guo X, Shi Y, Du P, Wang J, Han Y, Sun B, et al. HMGB1/TLR4 promotes apoptosis and reduces autophagy of hippocampal neurons in diabetes combined with OSA. Life Sci. 2019;239:117020. https://doi.org/10.1016/j.lfs.2019.117020
  • Wu CZ, Zheng JJ, Bai YH, Xia P, Zhang HC, Guo Y. HMGB1/RAGE axis mediates the apoptosis, invasion, autophagy, and angiogenesis of the renal cell carcinoma. Onco Targets Ther. 2018;11:4501-4510. https://doi.org/10.2147/OTT.S167197
  • Anderson HL, Brodsky IE, Mangalmurti NS. The Evolving Erythrocyte: Red Blood Cells as Modulators of Innate Immunity. J Immunol. 2018;201(5):1343-1351. https://doi.org/10.4049/jimmunol.1800565